Will Top-Line Improvement Benefit AppLovin's Q2 Earnings?
The consensus estimate for the Advertising revenues is pegged at $1.23 billion, indicating 72% year-over-year growth. This surge is likely to have been fueled by the company's advanced Axon 2 technology, which enhances ad targeting and optimization. Since its debut, Axon 2 has radically enhanced AppLovin's ad performance, helping to quadruple advertising spend on its platform. The Zacks Consensus Estimate for AppLovin's total revenues is expected to reach $1.21 billion, indicating a robust 12.3% increase from the year-ago quarter.
AppLovin Corporation Price and EPS Surprise
AppLovin Corporation price-eps-surprise | AppLovin Corporation Quote
Profitability is also anticipated to have improved significantly. The consensus estimate for Advertising's adjusted EBITDA is pegged at $1000 million, implying 92.3% year-over-year growth. Earnings per share are expected to show a massive 123.6% increase, with the Zacks Consensus Estimate at $1.99. These projections highlight AppLovin's ability to capitalize on its technology-driven business model, reinforcing its position as a leading player in the digital advertising and gaming industries.
APP currently carries a Zacks Rank #3 (Hold).
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Earnings Snapshot
Fiserv, Inc. FI reported mixed second-quarter 2025 results, wherein earnings beat the Zacks Consensus Estimate, but revenues missed the same.
FI's adjusted EPS of $2.47 topped the consensus mark by 2.5% and rose 16% year over year. Adjusted revenues of $5.2 billion missed the consensus estimate by a slight margin but gained 1.7% on a year-over-year basis.
The Interpublic Group of Companies, Inc. IPG reported impressive second-quarter 2025 results. Both earnings and revenues beat the Zacks Consensus Estimate.
IPG's adjusted earnings of 75 cents per share surpassed the Zacks Consensus Estimate by 36.4% and jumped 23% from the year-ago quarter. Revenues before billable expenses (net revenues) of $2.2 billion beat the consensus estimate by a slight margin but declined 19.8% year over year. Total revenues of $2.5 billion decreased 7.2% year over year but outpaced the Zacks Consensus Estimate of $2.2 billion.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Interpublic Group of Companies, Inc. (The) (IPG) : Free Stock Analysis Report
AppLovin Corporation (APP) : Free Stock Analysis Report
Fiserv, Inc. (FI) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Should You Buy This ‘Top Pick' Stock That Wall Street Loves?
AppLovin (APP) was historically known as a leading mobile app company that provided end-to-end software and solutions that helped businesses and app developers market, monetize, analyze, and publish their apps globally. In recent times, the company has shifted toward advertising technology as it divests its gaming development division. About AppLovin Stock AppLovin's stock has a YTD return of 42%, dramatically outpacing the S&P 500 Index's ($SPX) 8.7% climb. Over the past 12 months, AppLovin shares have soared by nearly 500% and are now trading 12% below their 52-week high set in February. The stock is also up 21% in the past 5 days and 33% in a month. More News from Barchart 1 'Strong Buy' Defense Stock to Snag Instead of Palantir Is Qualcomm the Best Semiconductor Stock to Buy Right Now? A $10 Billion Reason to Buy Palantir Stock Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! AppLovin's Stellar Results AppLovin posted its second-quarter results on Aug. 6, in which it easily outperformed estimates on both earnings and revenue. The company posted earnings of $2.26 per adjusted share, beating Wall Street's $1.99 per share estimate. Revenue surged 77% to $1.26 billion, topping the analyst estimate of $1.21 billion. Net income from continuing operations soared 156% to $772 million, driven by strong performance in AppLovin's advertising technology segment as the business sharpened its focus on AI-powered ad solutions after divesting the gaming apps division. Other financial highlights include remarkable adjusted EBITDA of $1.02 billion, up 99% year-over-year. AppLovin ended the quarter with $1.2 billion in cash and equivalents as free cash flow spiked 72% to $768 million during Q2. Looking ahead, AppLovin guided for Q3 2025 revenue between $1.32 billion and $1.34 billion, and adjusted EBITDA of $1.07 billion to $1.09 billion, signaling expectations for continued high growth and sustained healthy margins. AppLovin Named 'Top Pick' by Analyst AppLovin shares surged following Q2 earnings and received renewed optimism from analysts. Oppenheimer analysts Martin Yang and Jason Helfstein have named the company as their 'top pick' with an 'Outperform' rating and a price target of $500, indicating upside potential of 9.2%. The analysts highlighted management's increasing confidence that e-commerce advertising will exceed 10% of total ad revenue this year, pointing toward the AXON Ad Manager launch along with a new self-service portal for U.S. and international clients coming on Oct. 1. Bank of America also reiterated a 'Buy' rating, raising its price target to $580, reflecting 26% upside from the market price. BofA cited several reasons for the raise, such as the introduction of the advertiser referral program slated to launch in October, expanded access for global advertisers, and plans to open AppLovin's platform to small and medium businesses in 2026. Lastly, Benchmark Equity Research echoed the positive sentiment, maintaining its 'Buy' rating and a price target of $525, signaling 15% upside. Analyst Mike Hickey pointed to rising advertiser confidence, enhanced performance from AXON technology, and broader global reach as reasons AppLovin is well-positioned for sustained revenue and margin expansion. Should You Buy AppLovin? AppLovin has strong support from market experts on Wall Street, as seen by the consensus 'Strong Buy' rating and a mean price target of $474.73, reflecting upside potential of 4%. The stock has been covered by 22 analysts with 18 'Strong Buy' ratings, three 'Hold' ratings, and one 'Strong Sell' rating. On the date of publication, Ruchi Gupta did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
Yahoo
2 hours ago
- Yahoo
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics. Is This 1 Momentum Stock a Screaming Buy Right Now? For momentum investors, upward or downward trends in a stock's price or earnings outlook take precedent, so they'll want to zero in on the Momentum Style Score. This Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates. Wheaton Precious Metals Corp. (WPM) Wheaton Precious Metals is one of the largest precious metal streaming companies in the world that generates its revenues from the sale of precious metals and cobalt. WPM boasts a Momentum Style Score of A and VGM Score of B, and holds a Zacks Rank #3 (Hold) rating. Shares of Wheaton Precious Metals Corp. has seen some interesting price action recently; the stock is up 9.1% over the past one week and up 11% over the past four weeks. And in the last one-year period, WPM has gained 83.5%. As for the stock's trading volume, 1,757,803 shares on average were traded over the last 20 days. Momentum investors also pay close attention to a company's earnings. For WPM, 12 analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.25 to $2.32 per share for 2025. WPM boasts an average earnings surprise of 4.7%. WPM should be on investors' short list because of its impressive earnings fundamentals, a good Zacks Rank, and strong Momentum and VGM Style Scores. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Wheaton Precious Metals Corp. (WPM) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
16 hours ago
- Yahoo
LifeStance Health Group (LFST) Reports Q2 Loss, Tops Revenue Estimates
LifeStance Health Group (LFST) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.06 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +66.67%. A quarter ago, it was expected that this outpatient mental health services provider would post a loss of $0.04 per share when it actually produced break-even earnings, delivering a surprise of +100%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. LifeStance Health, which belongs to the Zacks Medical - Outpatient and Home Healthcare industry, posted revenues of $345.31 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.02%. This compares to year-ago revenues of $312.33 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. LifeStance Health shares have lost about 47.1% since the beginning of the year versus the S&P 500's gain of 7.9%. What's Next for LifeStance Health? While LifeStance Health has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for LifeStance Health was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.01 on $359.78 million in revenues for the coming quarter and -$0.06 on $1.42 billion in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Outpatient and Home Healthcare is currently in the top 27% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. Another stock from the same industry, RadNet (RDNT), has yet to report results for the quarter ended June 2025. The results are expected to be released on August 10. This operator of medical diagnostic imaging centers is expected to post quarterly earnings of $0.17 per share in its upcoming report, which represents a year-over-year change of +6.3%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. RadNet's revenues are expected to be $488.57 million, up 6.3% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report LifeStance Health Group, Inc. (LFST) : Free Stock Analysis Report RadNet, Inc. (RDNT) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
